Last reviewed · How we verify
SA4Ag vaccine high dose
SA4Ag vaccine high dose is a Biologic drug developed by Pfizer. It is currently in Phase 1 development.
At a glance
| Generic name | SA4Ag vaccine high dose |
|---|---|
| Sponsor | Pfizer |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years (PHASE1)
- Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SA4Ag vaccine high dose CI brief — competitive landscape report
- SA4Ag vaccine high dose updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about SA4Ag vaccine high dose
What is SA4Ag vaccine high dose?
SA4Ag vaccine high dose is a Biologic drug developed by Pfizer.
Who makes SA4Ag vaccine high dose?
SA4Ag vaccine high dose is developed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What development phase is SA4Ag vaccine high dose in?
SA4Ag vaccine high dose is in Phase 1.
Related
- Manufacturer: Pfizer — full pipeline
- Compare: SA4Ag vaccine high dose vs similar drugs
- Pricing: SA4Ag vaccine high dose cost, discount & access